The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

Medicine and Dentistry

• Glycon 80%
• Glucose 40%
• Inpatient 30%
• Combination Therapy 20%
• Patient with Type 2 Diabetes 20%
• Patient 20%
• Plasma 20%
• Group Therapy 10%
• Antidiabetic Agent 10%
• Glycemic Control 10%
• Maturity Onset Diabetes of the Young 10%
• Research Design 10%
• Cell Function 10%
• Adverse Event 10%
• Placebo-Controlled Study 10%
• Glucagon 10%
• C-Peptide 10%
• Analysis of Covariance 10%
• Body Weight Loss 10%
• Add on Therapy 10%
• Glycemic Index 10%
• Observation 10%
• Incidence 10%
• Amaurosis 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Saxagliptin 70%
• Glucose 40%
• Adverse Event 10%
• Insulin 10%
• Non Insulin Dependent Diabetes Mellitus 10%
• Placebo-Controlled Study 10%
• C Peptide 10%
• Glucagon 10%
• Antidiabetic Agent 10%
• Incidence 10%
• Blindness 10%